New Marketrack360™ Forecasts Company-Reported Business Segment Sales Prior to Earnings Releases

March 22, 2010

Decision Resources, Inc. Acquires Biotrends

January 19, 2010

Decision Resources, Inc. Announces Key Strategic Promotions Including Chief Commercialization Officer Mark Bard

January 12, 2010

HealthLeaders-InterStudy Market Analyst Taylor Holliday quoted in Crain’s Cleveland Business journal

July 26, 2010

Millennium Research Group data quoted on Bloomberg.com

July 23, 2010

Decision Resources Analyst Natalie Taylor, Ph.D. quoted on The Pink Sheet

July 22, 2010

Webinar: Will Effient, Brilinta and Other Novel Oral Antiplatelets Gain Widespread Physician and Payer Acceptance in ACS and CHD?

August 11, 2010

Analyst Call: Who Will Be the Winners and Losers in the Obesity Wars? Fallout from the FDA Advisory Committee’s Vote on Qnexa - On Demand

August 3, 2010

Based on our Pharmacor advisory service entitled Obesity, Decision Resources is offering an exclusive analyst call entitled Who Will Be the Winners and Losers in the Obesity Wars? Fallout from the FDA Advisory Committee’s Vote on Qnexa.  Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

This analyst call will be held on August 3, 2010. Contact us to learn how you can purchase this service and attend the analyst call.

Click here to view the invite.

Analyst Call: A Crushing Blow for Avastin? Assessing the Impact of an FDA Panel’s 12 to 1 Vote to Withdraw Avastin’s Marketing Approval for Breast Cancer - On Demand

July 29, 2010

Based on our Pharmacor advisory service entitled Breast Cancer, Decision Resources is offering an exclusive analyst call entitled A Crushing Blow for Avastin? Assessing the Impact of an FDA Panel’s 12 to 1 Vote to Withdraw Avastin’s Marketing Approval for Breast Cancer. Because this presentation will feature major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

This analyst call will be held on July 29, 2010. Contact us to learn how you can purchase this service and attend the analyst call.

Click here to view the invite.